These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33657432)

  • 1. Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds.
    Liu Y; Chang S; Hsieh D; Burdette D; Martin R; Mo H; Feierbach B
    J Virol Methods; 2021 Jun; 292():114117. PubMed ID: 33657432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
    Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro.
    Verbinnen T; Tan Y; Wang G; Dehertogh P; Vergauwen K; Neefs JM; Jacoby E; Lenz O; Berke JM
    J Antimicrob Chemother; 2020 Sep; 75(9):2526-2534. PubMed ID: 32417895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro.
    Liu Y; Miller MD; Kitrinos KM
    Antiviral Res; 2017 Mar; 139():25-31. PubMed ID: 28017761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
    Ruan L; Hadden JA; Zlotnick A
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy.
    Kim H; Ko C; Lee JY; Kim M
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro.
    Berke JM; Tan Y; Verbinnen T; Dehertogh P; Vergauwen K; Vos A; Lenz O; Pauwels F
    Antiviral Res; 2017 Aug; 144():205-215. PubMed ID: 28647474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators.
    Nayak S; Gowda J; Abbas SA; Kim H; Han SB
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging.
    Wu S; Luo Y; Viswanathan U; Kulp J; Cheng J; Hu Z; Xu Q; Zhou Y; Gong GZ; Chang J; Li Y; Guo JT
    Antiviral Res; 2018 Nov; 159():1-12. PubMed ID: 30201396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazepinone HBV capsid assembly modulators.
    Kuduk SD; DeRatt LG; Stoops B; Shaffer P; Lam AM; Espiritu C; Vogel R; Lau V; Flores OA; Hartman GD
    Bioorg Med Chem Lett; 2022 Sep; 72():128823. PubMed ID: 35644301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
    Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
    Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.
    Yin J; Feng Z; Li Z; Hu J; Hu Y; Cai X; Zhou H; Wang K; Tang N; Huang A; Huang L
    Eur J Med Chem; 2023 Mar; 249():115141. PubMed ID: 36709646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR.
    Lecoq L; Brigandat L; Huber R; Fogeron ML; Wang S; Dujardin M; Briday M; Wiegand T; Callon M; Malär A; Durantel D; Burdette D; Berke JM; Meier BH; Nassal M; Böckmann A
    Nat Commun; 2023 Jan; 14(1):471. PubMed ID: 36709212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Di-fluoro azepane HBV capsid assembly modulators.
    DeRatt LG; Stoops B; Shaffer P; Lam AM; Espiritu C; Vogel R; Lau V; Flores OA; Kuduk SD
    Bioorg Med Chem Lett; 2023 Aug; 92():129350. PubMed ID: 37247697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly.
    Xi J; Gu Z; Sun C; Chen Z; Zhang T; Chen R; Liu T; Liao H; Zou J; Yang D; Xu Q; Wang J; Wei G; Cheng Z; Lu F; Chen X
    Antiviral Res; 2023 Oct; 218():105715. PubMed ID: 37683938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.